OLUX Drug Patent Profile

✉ Email this page to a colleague

When do Olux patents expire, and what generic alternatives are available?

Olux is a drug marketed by Mylan and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in OLUX is clobetasol propionate. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Olux

A generic version of OLUX was approved as clobetasol propionate by COSETTE on February 16^th, 1994.

Try a Trial

Summary for OLUX

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	80
Patent Applications:	4,476
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for OLUX
What excipients (inactive ingredients) are in OLUX?	OLUX excipients list
DailyMed Link:	OLUX at DailyMed

Drug patent expirations by year for OLUX

Anatomical Therapeutic Chemical (ATC) Classes for OLUX

D07AD	Corticosteroids, very potent (group IV)
D07A	CORTICOSTEROIDS, PLAIN
D07	CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

Paragraph IV (Patent) Challenges for OLUX

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OLUX	Topical Foam	clobetasol propionate	0.05%	021142	1	2005-06-27

US Patents and Regulatory Information for OLUX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	OLUX	clobetasol propionate	AEROSOL, FOAM;TOPICAL	021142-001	May 26, 2000		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Mylan	OLUX E	clobetasol propionate	AEROSOL, FOAM;TOPICAL	022013-001	Jan 12, 2007		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Mylan	OLUX E	clobetasol propionate	AEROSOL, FOAM;TOPICAL	022013-001	Jan 12, 2007		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for OLUX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	OLUX	clobetasol propionate	AEROSOL, FOAM;TOPICAL	021142-001	May 26, 2000	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for OLUX

See the table below for patents covering OLUX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Portugal	813413		⤷ Try a Trial
Austria	253367		⤷ Try a Trial
European Patent Office	0813413	MOUSSE CONTENANT UN CORTICOSTEROIDE (CORTICOSTEROID-CONTAINING FOAM)	⤷ Try a Trial
New Zealand	302727	FOAMABLE CORTICOSTEROID COMPOSITION	⤷ Try a Trial
Hungary	228890	CORTICOSTEROID-CONTAINING FOAM AND USE THEREOF	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for OLUX

Anatomical Therapeutic Chemical (ATC) Classes for OLUX

Paragraph IV (Patent) Challenges for OLUX

Make Better Decisions: Try a trial or see plans & pricing